Chitin synthesis inhibitors promote liver cancer cell metastasis via interfering with hypoxia-inducible factor 1 alpha

Chitin synthesis inhibitors (CSIs), as alternatives to conventional insecticides, have been in worldwide demand in recent years. However, little attention has been paid to the potential ecological safety and health risks of CSIs, especially their abilities to interfere with nonsexual hormone receptors such as hypoxia-inducible factor la (HIF-1 alpha). In this work, we conducted a systematic study regarding the influence of CSIs on HIF-1 alpha-related liver cancer cell metastasis. The dual-luciferase reporter gene assay revealed that two of fourteen CSIs exhibited dose-response HIF-1 alpha agonistic activities at noncytotoxic concentrations with relative luciferase activity (RLA) values of 25.6% for diflubenzuron (DFB) and 20.9% for triflumuron (TFM). Following this result, in vitro bioassays demonstrated that both DFB and TFM stimulated HepG2 cell migration and invasion. This action was associated with the varied expression levels of genes involved in epithelial-to-mesenchymal transition (EMT) activation and extracellular matrix (ECM) degradation, such as the upregulation of fibronectin (FN1) and matrix metalloproteinase-2 (MMP-2) and the suppression of E-cadherin (E-cad) and tissue inhibitor of metalloproteinases-2 (TIMP2). Moreover, changes in these EMT and ECM phenotype markers were dramatically blocked by a HIF-1 alpha inhibitor (KC7F2), which further verified the involvement of HIF-1 alpha in CSI-induced HepG2 cell metastasis. For the first time, our findings reveal that CSIs play crucial roles in promoting the metastasis of human liver cancer cells and that HIF-1 alpha is potentially responsible for these changes. (C) 2018 Elsevier Ltd. All rights reserved.